1-(β-D-Xylofuranosyl)-5-methylcytosine

Modify Date: 2024-01-29 17:40:07

1-(β-D-Xylofuranosyl)-5-methylcytosine structure	Common Name	1-(β-D-Xylofuranosyl)-5-methylcytosine
	CAS Number	18492-10-9	Molecular Weight	257.24
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₀H₁₅N₃O₅	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of 1-(β-D-Xylofuranosyl)-5-methylcytosine

1-(β-D-Xylofuranosyl)-5-methylcytosine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].

Name	1-(β-D-Xylofuranosyl)-5-methylcytosine

Description	1-(β-D-Xylofuranosyl)-5-methylcytosine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog
References	[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. [2]. Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8.

Description

Related Catalog

Research Areas >> Cancer

Signaling Pathways >> Cell Cycle/DNA Damage >> Nucleoside Antimetabolite/Analog

References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

[2]. Gowher H, et al. Mechanism of inhibition of DNA methyltransferases by cytidine analogs in cancer therapy. Cancer Biol Ther. 2004 Nov;3(11):1062-8.

Molecular Formula	C₁₀H₁₅N₃O₅
Molecular Weight	257.24

1-(β-D-Xylofuranosyl)-5-methylcytosine

Use of 1-(β-D-Xylofuranosyl)-5-methylcytosine

Names

1-(β-D-Xylofuranosyl)-5-methylcytosine Biological Activity

Chemical & Physical Properties